bioAffinity Technologies, Inc.

BIAF
$1.52 (+ $0.01 + 0.66%)
Last updated: 2026-06-11 02:39 UTC
BIAF Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS09076W3079
CUSIP09076W307
Market Price1.52
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-13.83
Market Cap$5.5M
Book Value2.57
Price to Book0.478
Beta2.42
52w High46.53
52w Low1.18
Next Earnings DateN/A

bioAffinity Technologies, Inc. trades under ticker BIAF on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US09076W3079, CUSIP 09076W307.

About the Company
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Price History